Picture of Precision Biosciences logo

DTIL — Precision Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Precision BioSciences Inc reports results for the quarter ended in December - Earnings Summary

* Precision BioSciences Inc  DTIL.OQ  reported a quarterly
adjusted loss of $4.06​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of $-7.80.  The mean expectation of
four analysts for the quarter was for a loss of $2.05 per share.
Wall Street expected results to range from $-5.10 to $3.00 per
share.
    * Revenue fell 33.6% to $7.04 million from a year ago;
analysts
expected $12.48 million. 
    * Precision BioSciences Inc's reported EPS for the quarter
was a
loss of $4.06​.
    * The company reported a quarterly loss of $16.29 million.
    * Precision BioSciences Inc shares had risen by 16.4% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Precision
BioSciences Inc is $75.00 
This summary was machine generated from LSEG data March 27 at
01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -2.05          -4.06          Missed
 Sep. 30 2023      -4.87          -2.10          Beat
 Jun. 30 2023      -7.32          -3.00          Beat
 Mar. 31 2023      -6.78          -6.90          Missed

Recent news on Precision Biosciences

See all news